Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sep 3, 2010


Shimadzu this week introduced its LCMS-8030 triple quadrupole mass spectrometer.

The instrument features scan speeds of up to 15,000 u/sec and can perform up to 500 MRMs per second, allowing it to keep up with the faster chromatographic peaks provided by high performance chromatography, the company said. Additionally, the instrument comes with software that allows for simple integration of Shimadzu's LC product lines.

HealthLinx this week announced that it has launched sales in Singapore of its protein biomarker-based ovarian cancer diagnostic OvPlex.

The company's Singapore distribution partner Innovation Exchange is offering OvPlex through Quest Laboratories at a cost of SGD$300 ($223) per test. Singapore is the third country in which the test is available after Australia and the United Kingdom.

Protein Discovery this week launched its YPX Yeast Protein Extraction Kit, which extracts proteins from yeast cells without using mechanical disruption.

The YPX kits extract the entire yeast proteome with "near complete efficiency," making it particularly useful for quantitative proteomic workflows, and is faster and produces higher protein yield compared to conventional methods, the company said.

GenScript announced this week that purchases of its magnetic beads products and epitope tag antibodies are 25 percent off until Nov. 30.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.